valproic acid has been researched along with corticosterone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Cha, SH; Endou, H; Fukushima , JI; Goya, T; Kanai, Y; Kobayashi, Y; Sekine, T | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Knight, DL; Lindsey, KP; Nemeroff, CB; Owens, MJ; Stout, SC | 1 |
| Gilmor, ML; Nemeroff, CB; Owens, MJ; Skelton, KH | 1 |
| Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
| Barbier, E; Wang, JB | 1 |
| Chen, LH; Cheng, LY; Cherng, CG; Kao, GS; Su, CC; Tzeng, WY; Wang, CY; Yu, L | 1 |
| Depino, AM; Lucchina, L | 1 |
| Fei, HZ; Hu, XY; Liu, D; Qiu, HM; Yang, JX; Zhou, QX | 1 |
| Douma, TN; Groenink, L; Millan, MJ; Olivier, B; Oosting, RS; Verdouw, PM | 1 |
| Duan, S; Han, Y; Li, X; Lou, H; Lu, Y; Zhen, X; Zhou, R; Zhu, L | 1 |
| Kim, I; Olatunji, LA; Omolekulo, TE; Usman, TO | 1 |
| Goel, RK; Singh, T | 1 |
| Areola, ED; Badmus, OO; Kim, I; Michael, OS; Olatunji, LA; Omolekulo, TE | 1 |
| Goel, RK; Kaur, S; Sharma, NK | 1 |
| Barati, M; Eslami, M; Goudarzi, M; Mehrabi, S; Nahavandi, A; Shahbazi, A | 1 |
1 review(s) available for valproic acid and corticosterone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
18 other study(ies) available for valproic acid and corticosterone
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; Gene Library; Humans; Kidney Tubules, Proximal; Molecular Sequence Data; Oocytes; Organic Anion Transporters, Sodium-Independent; Sequence Homology, Amino Acid; Tissue Distribution; Transfection; Xenopus laevis | 2001 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Effects of sodium valproate on corticotropin-releasing factor systems in rat brain.
Topics: Animals; Anticonvulsants; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Administration Schedule; Hypothalamo-Hypophyseal System; Male; Neurons; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Synapses; Valproic Acid | 2001 |
The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.
Topics: Adrenocorticotropic Hormone; Animals; Antimanic Agents; Autoradiography; Corticosterone; Corticotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Image Processing, Computer-Assisted; In Situ Hybridization; Lithium Carbonate; Male; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Urocortins; Valproic Acid; Weight Gain | 2003 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level.
Topics: Analysis of Variance; Animals; Anxiety; Avoidance Learning; Behavior, Animal; Corticosterone; Cues; Depression; Exploratory Behavior; Hindlimb Suspension; Hypothalamo-Hypophyseal System; Immobility Response, Tonic; Male; Maze Learning; Mental Recall; Mice; Mice, Knockout; Nerve Tissue Proteins; Pituitary-Adrenal System; Regression Analysis; Spatial Behavior; Swimming; Time Factors; Valproic Acid | 2009 |
Neonatal isolation decreases cued fear conditioning and frontal cortical histone 3 lysine 9 methylation in adult female rats.
Topics: Acoustic Stimulation; Age Factors; Animals; Animals, Newborn; Azacitidine; Behavior, Animal; Cerebral Cortex; Conditioning, Psychological; Corticosterone; Cues; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Down-Regulation; Estradiol; Fear; Female; Histone Deacetylase Inhibitors; Histones; Light; Lysine; Maternal Deprivation; Methylation; Photic Stimulation; Rats; Rats, Sprague-Dawley; Reflex, Startle; Stress, Psychological; Valproic Acid | 2012 |
Altered peripheral and central inflammatory responses in a mouse model of autism.
Topics: Animals; Cerebellum; Child Development Disorders, Pervasive; Corticosterone; Cytokines; Female; Hippocampus; Inflammation Mediators; Lipopolysaccharides; Mice; Models, Genetic; Neuroglia; Pregnancy; Prenatal Exposure Delayed Effects; Real-Time Polymerase Chain Reaction; Valproic Acid | 2014 |
Antidepressive effect of sodium valproate involving suppression of corticotropin-releasing factor expression and elevation of BDNF expression in rats exposed to chronic unpredicted stress.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Corticosterone; Corticotropin-Releasing Hormone; Depressive Disorder; Gene Expression; Hippocampus; Hypothalamus; Male; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Task Performance and Analysis; Valproic Acid | 2014 |
Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activation.
Topics: Animals; Antimanic Agents; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; GABA Agents; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Histone Deacetylase Inhibitors; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Receptors, GABA-A; Receptors, GABA-B; Reflex, Startle; Sensory Gating; Valproic Acid | 2014 |
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Topics: Adaptation, Ocular; Animals; Antidepressive Agents; Bipolar Disorder; Cathepsin D; Corticosterone; Depression; Dextroamphetamine; Disease Models, Animal; Exploratory Behavior; Female; Food Preferences; Hyperkinesis; Lithium Chloride; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Ceroid-Lipofuscinoses; Sleep Wake Disorders; Swimming; Valproic Acid | 2015 |
Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone.
Topics: Animals; Anticonvulsants; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Female; Glucose Intolerance; Glucose Tolerance Test; Rats; Rats, Wistar; Valproic Acid | 2016 |
Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression.
Topics: Animals; Comorbidity; Corticosterone; Depression; Drug Interactions; Enzyme Inhibitors; Epilepsy; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Minocycline; Neurotransmitter Agents; Nitrites; Time Factors; Valproic Acid | 2016 |
Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen-progestin.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Aldosterone; Animals; Contraceptives, Oral, Combined; Corticosterone; Disease Models, Animal; Estrogens; Female; Glucose; Humans; Hypertension; Liver; Progestins; Rats; Rats, Wistar; Triglycerides; Uric Acid; Valproic Acid; Xanthine Oxidase | 2018 |
Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anticonvulsants; Corticosterone; Depression; Dose-Response Relationship, Drug; Epilepsy; Kindling, Neurologic; Male; Memory Disorders; Mice; Pentylenetetrazole; Phenytoin; Valproic Acid | 2020 |
Valproic acid administration exerts protective effects against stress-related anhedonia in rats.
Topics: Anhedonia; Animals; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Histone Deacetylase Inhibitors; Rats; Recognition, Psychology; Stress, Psychological; Valproic Acid | 2020 |